الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
12 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
13 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
14 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Prof. Ashraf Zeidan Abdalla Ahmed 2023
15 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Salah Mabrouk Khallaf Abd Rabou 2023
16 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Dr. Marwa Tammam Ameen Hammam 2023
17 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Dr. Mayada Fawzy Sedik Farghaly 2021
18 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Doaa Mohamed Fouad Mahmoud 2021
19 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		Dr. Mayada Fawzy Sedik Farghaly 2021
20 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Ahmed Refaat Abdel Zaher Mubarak 2021